Semi-Annual Statement Of Income And Retained Earnings

KYORIN Pharmaceutical Co., Ltd. - Filing #7257328

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
12,567,000,000 JPY
12,902,000,000 JPY
6,234,000,000 JPY
6,893,000,000 JPY
Non-operating income
Non-operating income
870,000,000 JPY
990,000,000 JPY
735,000,000 JPY
804,000,000 JPY
Non-operating expenses
Non-operating expenses
218,000,000 JPY
187,000,000 JPY
146,000,000 JPY
66,000,000 JPY
Ordinary profit (loss)
13,219,000,000 JPY
13,706,000,000 JPY
6,822,000,000 JPY
7,632,000,000 JPY
Extraordinary income
Extraordinary income
103,000,000 JPY
0 JPY
1,404,000,000 JPY
48,537,000,000 JPY
Extraordinary losses
Extraordinary losses
551,000,000 JPY
486,000,000 JPY
987,000,000 JPY
938,000,000 JPY
Profit (loss) before income taxes
12,770,000,000 JPY
13,219,000,000 JPY
7,239,000,000 JPY
55,231,000,000 JPY
Income taxes - current
3,807,000,000 JPY
4,167,000,000 JPY
1,897,000,000 JPY
2,046,000,000 JPY
Income taxes - deferred
-123,000,000 JPY
-329,000,000 JPY
-133,000,000 JPY
40,000,000 JPY
Profit (loss)
9,086,000,000 JPY
9,382,000,000 JPY
9,382,000,000 JPY
9,382,000,000 JPY
9,382,000,000 JPY
53,144,000,000 JPY
5,475,000,000 JPY
53,144,000,000 JPY
53,144,000,000 JPY
53,144,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.